Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Nadeu

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Haematologica|April 11, 2020
Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center studyLesley-Ann Sutton, Viktor Ljungström, Anna Enjuanes, et al.
Blood|September 22, 2025
Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemiaJudith Mateos-Jaimez, Anna Vidal-Crespo, Stella Charalampopoulou, et al.
Leukemia & Lymphoma|November 9, 2017
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemiaAlejandra Martínez-Trillos, Magda Pinyol, Julio Delgado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2022
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialEva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, et al.
Blood Advances|March 30, 2023
Unraveling the genetics of transformed splenic marginal zone lymphomaMarta Grau, Cristina López, Alba Navarro, et al.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Blood Cancer Journal|May 2, 2024
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic targetCèlia Dobaño-López, Juan García Valero, Ferran Araujo-Ayala, et al.
Blood|January 22, 2025
Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemiaVicente Chapaprieta, Alba Maiques-Diaz, Ferran Nadeu, et al.
Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Haematologica|April 11, 2020
Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center studyLesley-Ann Sutton, Viktor Ljungström, Anna Enjuanes, et al.
Blood|September 22, 2025
Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemiaJudith Mateos-Jaimez, Anna Vidal-Crespo, Stella Charalampopoulou, et al.
Leukemia & Lymphoma|November 9, 2017
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemiaAlejandra Martínez-Trillos, Magda Pinyol, Julio Delgado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2022
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialEva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, et al.
Blood Advances|March 30, 2023
Unraveling the genetics of transformed splenic marginal zone lymphomaMarta Grau, Cristina López, Alba Navarro, et al.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Blood Cancer Journal|May 2, 2024
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic targetCèlia Dobaño-López, Juan García Valero, Ferran Araujo-Ayala, et al.
Blood|January 22, 2025
Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemiaVicente Chapaprieta, Alba Maiques-Diaz, Ferran Nadeu, et al.
Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.
Pageof 9